Medtronic plc financials

MDT CIK 0001613103

Source: EDGAR filings · Built 2026-08-18T00:18:19Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Free Cash Flow 5.43B 5.18B 5.20B 4.58B 5.98B 4.88B
EBITDA 9.43B 8.82B 7.79B 8.18B 8.46B 7.19B
Working Capital 13.13B 10.94B 11.15B 12.62B 10.66B 14.04B
Net Debt 25.41B 24.53B 24.75B 23.85B 17.53B 23.80B
Gross Margin 65.02% 65.32% 65.34% 65.67% 67.98% 65.19%
Operating Margin 17.78% 17.76% 15.89% 17.56% 18.15% 14.89%
Net Margin 13.20% 13.90% 11.36% 12.03% 15.90% 11.97%
Return on Equity (ROE) 9.71% 9.71% 7.32% 7.30% 9.59% 7.01%
Return on Assets (ROA) 5.16% 5.09% 4.09% 4.13% 5.54% 3.87%
Current Ratio 2.13× 1.85× 2.03× 2.39× 1.86× 2.65×
Debt-to-Equity 0.55× 0.56× 0.52× 0.49× 0.40× 0.53×
Effective Tax Rate 21.17% 16.63% 23.42% 29.46% 8.27% 6.80%
Cash Conversion Ratio 1.53× 1.51× 1.85× 1.61× 1.46× 1.73×
Accruals Ratio -0.03× -0.03× -0.03× -0.03× -0.03× -0.03×
SBC % of Revenue 1.26% 1.28% 1.21% 1.14% 1.13% 1.14%
CapEx Coverage 3.85× 3.79× 4.28× 4.14× 5.37× 4.61×
Free Cash Flow Per Share $4.21 $4.02 $3.91 $3.44 $4.42 $3.61

Income Statement

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Revenue from Contract with Customer, Excluding Assessed Tax 36.36B 33.54B 32.36B 31.23B 31.69B 30.12B
Cost of Goods and Services Sold 12.72B 11.63B 11.22B 10.72B 10.14B 10.48B
Selling, General and Administrative Expense 11.78B 10.85B 10.74B 10.41B 10.29B 10.15B
Operating Income (Loss) 6.47B 5.96B 5.14B 5.49B 5.75B 4.48B
Income Tax Expense (Benefit) 1.30B 936.00M 1.13B 1.58B 456.00M 265.00M
Net Income (Loss) Attributable to Parent 4.80B 4.66B 3.68B 3.76B 5.04B 3.61B
Earnings Per Share, Basic $3.75 $3.63 $2.77 $2.83 $3.75 $2.68
Weighted Average Number of Shares Outstanding, Basic 1.28B 1.29B 1.33B 1.33B 1.34B 1.34B
Earnings Per Share, Diluted $3.73 $3.61 $2.76 $2.82 $3.73 $2.66
Weighted Average Number of Shares Outstanding, Diluted 1.29B 1.29B 1.33B 1.33B 1.35B 1.35B

Balance Sheet

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Cash and Cash Equivalents, at Carrying Value 1.95B 2.22B 1.28B 1.54B 3.71B 3.59B
Assets, Current 24.79B 23.81B 21.93B 21.68B 23.06B 22.55B
Assets 93.03B 91.68B 89.98B 90.95B 90.98B 93.08B
Liabilities, Current 11.66B 12.88B 10.79B 9.05B 12.39B 8.51B
Liabilities 42.96B 43.42B 39.56B 39.28B 38.26B 41.48B
Stockholders' Equity Attributable to Parent 49.46B 48.02B 50.21B 51.48B 52.55B 51.43B
Common Stock, Shares, Outstanding 1.28B 1.28B 1.31B 1.33B 1.33B 1.35B

Cash Flow Statement

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Net Cash Provided by (Used in) Operating Activities 7.33B 7.04B 6.79B 6.04B 7.35B 6.24B
Payments to Acquire Property, Plant, and Equipment 1.90B 1.86B 1.59B 1.46B 1.37B 1.35B
Net Cash Provided by (Used in) Investing Activities -2.93B -1.94B -2.37B -3.49B -1.66B -2.87B
Payments for Repurchase of Common Stock 1.03B 3.23B 2.14B 645.00M 2.54B 652.00M
Net Cash Provided by (Used in) Financing Activities -4.75B -4.36B -4.45B -4.96B -5.34B -4.14B

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (MDT CIK 0001613103), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

ISRG

Intuitive Surgical, Inc.

UHS

UNIVERSAL HEALTH SERVICES, INC.

COO

The Cooper Companies, Inc.